Cargando…

Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial

BACKGROUND: Recent advances in the treatment algorithms of early breast cancer have markedly improved overall survival. However, anthracycline- and trastuzumab-associated cardiotoxicity may lead to dose-reduction or halt in potentially life-saving adjuvant cancer therapy. Early initiated neurohormon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mecinaj, A, Gulati, G, Heck, SL, Holte, E, Fagerland, MW, Larsen, AI, Blix, E.S, Geisler, J, Wethal, T, Omland, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474901/ https://www.ncbi.nlm.nih.gov/pubmed/34579775 http://dx.doi.org/10.1186/s40959-021-00115-w

Ejemplares similares

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
por: Heck, Siri Lagethon, et al.
Publicado: (2021)

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
por: Gulati, Geeta, et al.
Publicado: (2016)

Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
por: Gulati, Geeta, et al.
Publicado: (2017)

Manuel González Prada
por: González Prada, Manuel
Publicado: (1945)

Semblanza y circunstancias de Manuel González Prada /
por: Rovira, Catherine
Publicado: (1993)

Prevalence of ADHD in Accident Victims: Results of the PRADA Study
por: Kittel-Schneider, Sarah, et al.
Publicado: (2019)

Periodic Rosuvastatin or Atorvastatin Dosing Arrays (PRADA): Patient-Centered Practice
por: Christou, Theodore, et al.
Publicado: (2014)

PRADA: Portable Reusable Accurate Diagnostics with nanostar Antennas for multiplexed biomarker screening
por: Wen, Xiaona, et al.
Publicado: (2020)

The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
por: Omland, Torbjørn, et al.
Publicado: (2022)

A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial – the PRADA trial
por: Droitcourt, Catherine, et al.
Publicado: (2019)

Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study
por: Thiruchelvam, Paul T R, et al.
Publicado: (2022)

Rationale of the PAPAartis trial
por: Misfeld, Martin, et al.
Publicado: (2023)

Rationale for adjuvant measures in musculoskeletal diseases
por: Gast, Ulf
Publicado: (2013)

The Alliance AMBUSH Trial: Rationale and Design
por: Mahajan, Anita, et al.
Publicado: (2022)

Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
por: Wethal, T, et al.
Publicado: (2009)

Damage control laparotomy trial: design, rationale and implementation of a randomized controlled trial
por: Harvin, John A, et al.
Publicado: (2017)

Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs
por: Sisa, Ivan, et al.
Publicado: (2021)

Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study
por: Kåss, AS, et al.
Publicado: (2014)

Current Immunotherapies for Sarcoma: Clinical Trials and Rationale
por: Mitsis, Demytra, et al.
Publicado: (2016)

Protocol and Rationale for the International Lung Screening Trial
por: Lim, Kuan Pin, et al.
Publicado: (2020)

Rationale, design, and methods: A randomized placebo-controlled trial of an immunomodulatory probiotic intervention for Veterans with PTSD
por: Brenner, Lisa A., et al.
Publicado: (2022)

IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
por: Oude Rengerink, Katrien, et al.
Publicado: (2010)

Strength Training for Arthritis Trial (START): design and rationale
por: Messier, Stephen P, et al.
Publicado: (2013)

Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
por: Nury, E., et al.
Publicado: (2020)

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer
por: Slamon, Dennis J., et al.
Publicado: (2023)

The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
por: Hagström, Anna, et al.
Publicado: (2022)

Perspectives of the Working Group on Drug Trials including Collaborative Trials of the ISBD and rationale for new clinical trials
por: Assaad-Khalil, S
Publicado: (2003)

Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial
por: Chang, Anne B, et al.
Publicado: (2012)

Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial
por: Locher, Cosima, et al.
Publicado: (2021)

Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF)
por: Becher, Marc Ulrich, et al.
Publicado: (2021)

Corrigendum to Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer
Publicado: (2023)

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Getting inside acupuncture trials - Exploring intervention theory and rationale
por: Price, Sarah, et al.
Publicado: (2011)

The Intensive Diet and Exercise for Arthritis (IDEA) trial: design and rationale
por: Messier, Stephen P, et al.
Publicado: (2009)

Natural Supplements for COVID19—Background, Rationale, and Clinical Trials
por: Hermel, Melody, et al.
Publicado: (2021)

A rationale for dedicated trials of combination therapy in heart failure
por: Blumer, Vanessa, et al.
Publicado: (2022)

Adjuvant chemotherapy in carcinoma colon: Is there a rationale to change practice for Asian patients?
por: Rangarajan, Bharath, et al.
Publicado: (2013)

Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review
por: Ranaldi, Giovanni Tommaso, et al.
Publicado: (2020)

The strong rationale for the use of dexmedetomidine instead of fentanyl as adjuvant to ropivacaine for epidural anaesthesia
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol
por: Chang, Anne B, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_is5bemqvk6nschs69h8crr7nni